The American Society of Clinical Oncology (ASCO) is a global professional organization representing physicians and other oncology professionals who care for people with cancer. Founded in 1964, ASCO works to conquer cancer through research, education, and the promotion of the highest quality and equitable patient care. It provides a wide range of resources, including practice guidelines, scientific journals (such as the Journal of Clinical Oncology® and JCO® Oncology Practice), educational meetings (including the ASCO Annual Meeting), and advocacy efforts to advance cancer treatment and improve patient outcomes worldwide. ASCO has more than 45,000 members in over 150 countries.
Serves as the central hub for ASCO's global operations, including administration, development of educational programs and clinical guidelines, research support, policy and advocacy work, and membership services.
Modern office facilities within a contemporary office building, designed for collaboration and administrative efficiency. Features meeting spaces and technology to support global operations and a distributed workforce.
A mission-driven and collaborative environment focused on advancing cancer care worldwide. The culture emphasizes scientific rigor, continuous learning, innovation, equity, and a profound commitment to improving the lives of patients with cancer and their families.
Strategically located near Washington D.C., allowing for effective engagement in U.S. health policy and advocacy. The headquarters centralizes ASCO's efforts to support its global membership and advance its mission to conquer cancer.
ASCO supports oncologists and cancer care globally through its international membership of over 45,000 professionals in more than 150 countries. Its functions include disseminating research findings through its journals and meetings, offering educational programs (including international meetings, workshops, and online learning), developing and promoting international cancer care guidelines, fostering research collaborations, and leading global health initiatives. ASCO actively works with international partners and health organizations to address disparities in cancer care, improve access to quality treatment, and advance cancer control worldwide.
2318 Mill Road, Suite 800
Alexandria
Virginia
USA
Address: Avenue des Gaulois 7, 1040 Etterbeek, Belgium (ASCO-Association Internationale AISBL)
To advance ASCO's mission in Europe by engaging with regional stakeholders, contributing to cancer policy discussions, supporting the European oncology community, and fostering international cooperation on cancer care and research.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, American Society of Clinical Oncology (ASCO)' leadership includes:
American Society of Clinical Oncology (ASCO) has been backed by several prominent investors over the years, including:
Key leadership transitions primarily involve the annually rotating presidential roles within ASCO. In June 2023, Dr. Lynn M. Schuchter began her term as President, and Dr. Robin Zon as President-Elect. These are planned successions within the organization's governance. No other major unexpected C-suite executive hires or departures have been prominently announced in the last 12-18 months.
Discover the tools American Society of Clinical Oncology (ASCO) uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The most common email format used by the American Society of Clinical Oncology (ASCO) for its staff is the first_name.last_name@asco.org pattern. While other formats might exist in isolated cases, this is the predominant structure for professional correspondence.
[first].[last]@asco.org
Format
jane.doe@asco.org
Example
90%
Success rate
asco.org • May 23, 2024
The American Society of Clinical Oncology (ASCO) commended the U.S. House of Representatives for passing H.R. 1038, the Timely ReAuthorization of Necessary Stem-cell Programs Lays the groundwork for Advancement, and Improvements for Researchers, Treatment, and Hope Act (TRAILBLAZER Act). ASCO stated this legislation would improve access to clinical trials for cancer patients by allowing trial sponsors to cover non-medical costs for participants....more
asco.org • May 21, 2024
The American Society of Clinical Oncology (ASCO) has released an updated clinical practice guideline providing evidence-based recommendations for systemic therapy in patients with advanced hepatocellular carcinoma. The guideline incorporates new research findings and treatment options to aid clinicians in decision-making....more
Healio • May 15, 2024
The American Society of Clinical Oncology (ASCO) published a new clinical practice guideline focused on the prevention and management of chemotherapy-induced peripheral neuropathy (CIPN), a common and often debilitating side effect experienced by cancer patients undergoing certain chemotherapy treatments....more
ASCO Daily News / various oncology news outlets • May 31, 2024 - June 4, 2024 (Event Window)
The ASCO Annual Meeting, held in Chicago and online, showcased thousands of abstracts and presentations on the latest advances in cancer research, treatment, and patient care. Key themes included innovations in immunotherapy, targeted therapies, artificial intelligence in oncology, and efforts to improve health equity in cancer outcomes....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including American Society of Clinical Oncology (ASCO), are just a search away.